Abstract

BackgroundThe Medical Imaging Projection System (MIPS) projects indocyanine green (ICG) fluorescence images directly on the surgical field using a projection mapping technique. We conducted an observational study of sentinel lymph node (SLN) biopsy using the prototype MIPS; we found a high identification rate. However, the number of SLN-positive cases was small, and the sensitivity could not be evaluated. The aim of this study was to investigate the clinical usefulness of the MIPS assisted ICG fluorescence method using commercially available equipment.MethodsThis was a retrospective observational study. Patients with primary breast cancer who underwent SLN biopsy using the MIPS at Kyoto University Hospital from April to December 2020 were included in the study. The primary endpoints were the identification rate of SLNs and detection of positive SLNs by the MIPS. The secondary endpoint was the number of SLNs excised using the MIPS per patient. We also conducted a questionnaire survey focused on the utility of the MIPS; it involved doctors with an experience in using the MIPS.ResultsSeventy-nine patients (84 procedures) were included in the study. In 60 (71%) procedures, both the radioisotope (RI) method and MIPS were used. At least one SLN could be detected by the MIPS in all the procedures, with an identification rate of 100% (95% confidence interval 95.6–100%). A total of 19 (7%) positive SLNs were removed, which were identifiable by the MIPS. Among 57 patients in whom the MIPS and RI methods were used, there was no positive SLN only identified by the RI method. The results of the questionnaire survey showed that the MIPS enabled the operator and assistant to share the ICG fluorescence image in the surgical field and to communicate with each other easily.ConclusionThe current study demonstrated that the identification rate of SLNs using the MIPS was high, and the MIPS can be used for detecting positive SLNs. It was suggested that the MIPS will be useful in learning SLN biopsy procedures.

Highlights

  • Sentinel lymph node (SLN) biopsy is the standard of care for patients with clinically node-negative breast cancer

  • In 2018, we conducted an observational study of SLN biopsy using the prototype Medical Imaging Projection System (MIPS) in 56 patients (59 procedures) at our institution; the identification rate was comparable to that obtained with the indocyanine green (ICG) fluorescence method using a conventional near infrared (NIR) system

  • Among patients who underwent SLN biopsy after preoperative systemic therapy (PST), the identification rate of the MIPS was 100% and that of the RI method was 100%

Read more

Summary

Introduction

Sentinel lymph node (SLN) biopsy is the standard of care for patients with clinically node-negative breast cancer. The MIPS assisted ICG fluorescence method involves an accurate and continuous projection of ICG fluorescence signals, which enables a realtime navigation surgery for SLN biopsy without shifting the visual focus from the surgical field. In 2018, we conducted an observational study of SLN biopsy using the prototype MIPS in 56 patients (59 procedures) at our institution; the identification rate was comparable to that obtained with the ICG fluorescence method using a conventional NIR system. We conducted an observational study of sentinel lymph node (SLN) biopsy using the prototype MIPS; we found a high identification rate. The aim of this study was to investigate the clinical usefulness of the MIPS assisted ICG fluorescence method using commercially available equipment

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call